Dishman Carbogen Amcis Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹677.64 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.41 per cent from ₹851.40 crore. This corresponds to a year-on-year *(YoY) decline of 4.29 per cent.
Operating Profit
Operating Profit stands at ₹58.39 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 63.91 per cent from ₹161.80 crore. This corresponds to a year-on-year *(YoY) decline of 57.70 per cent.
PBDT
PBDT stands at ₹39.46 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.75 per cent from ₹134.92 crore. This corresponds to a year-on-year *(YoY) decline of 67.12 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-51.22 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 211.03 per cent from ₹46.13 crore. This corresponds to a year-on-year *(YoY) decline of 232.45 per cent.
Net Profit
Net Profit stands at ₹-57.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 366.24 per cent from ₹21.74 crore. This represents a 347.24 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Dishman Carbogen Amcis Ltd Earnings
- YOY
- QOQ
Dishman Carbogen Amcis Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dishman Carbogen Amcis Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Dishman Carbogen Amcis Ltd Financial Reports
Dishman Carbogen Amcis Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dishman Carbogen | 1.16% | -0.97% | -5.54% | -12.94% | -3.15% | -37.57% |
| SMS Pharma. | -0.15% | -0.34% | -6.41% | -3.74% | -6.31% | 52.24% |
| Solara Active | -3.53% | 20.90% | 25.54% | 10.87% | 30.16% | -1.70% |
| Ind-Swift Labs. | -1.24% | 5.12% | 45.09% | 149.41% | 131.77% | 240.77% |
| Hikal | 2.00% | 1.69% | -0.41% | 1.24% | 7.80% | -15.61% |
| Panacea Biotec | -0.22% | -0.71% | -6.86% | -1.96% | 22.64% | 2.00% |
| Sai Parenteral's | 0.02% | -1.64% | 0.62% | 10.56% | 33.22% | 33.22% |
Company Info
Company Information
WTD & Executive Director : Deohooti J Vyas
ED / Global MD / Promoter : Arpit J Vyas
Independent Non Exe. Director : KULIN NALINKANT SHAH
Independent Non Exe. Director : Hemantkumar J Bhatt
Independent Non Exe. Director : Margie S Parikh
Non-Exec & Non-Independent Dir : Dhaval R. Shah
Company Sec. & Compli. Officer : Shrima Dave